Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy
Status:
Withdrawn
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of methadone alone and in
combination with SAB378 for the treatment of painful HIV-associated neuropathy.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)